Corient Private Wealth LLC Cuts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Corient Private Wealth LLC trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 19.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 85,746 shares of the exchange traded fund’s stock after selling 20,259 shares during the quarter. Corient Private Wealth LLC’s holdings in SPDR S&P Biotech ETF were worth $7,458,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $141,284,000. Proficio Capital Partners LLC boosted its stake in shares of SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after acquiring an additional 911,686 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $55,529,000. Finally, J.Safra Asset Management Corp raised its stake in SPDR S&P Biotech ETF by 461.6% in the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock valued at $26,293,000 after purchasing an additional 240,415 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 1.0 %

Shares of XBI opened at $86.59 on Friday. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The stock has a market cap of $5.61 billion, a PE ratio of 11.47 and a beta of 0.99. The firm’s fifty day moving average is $89.64 and its two-hundred day moving average is $94.48.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.